Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Proper diagnosis is crucial to avoid overtreatment and complications in pregnant women with hyperthyroidism.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Hashimoto's can rarely change to Graves disease, needing careful monitoring.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The new assay can help develop products for hair re-growth.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

One cat with low thyroid hormone had growth issues, and another with high thyroid hormone had skin problems; both got better with treatment.

The patient's hypothyroidism improved with medication adjustments and careful management.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Blocking LFA-1 prevents hair loss in mice.

Tislelizumab can cause cutaneous lupus erythematosus.